Cargando...
Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
CONTEXT: Graves' orbitopathy (GO) is a potentially sight-threatening disease for which available medical therapy is not uniformly successful. Multiple case series suggest that rituximab (RTX) may be effective therapy for GO patients. OBJECTIVE: To determine the efficacy of RTX in GO. DESIGN: It...
Gardado en:
| Publicado en: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Endocrine Society
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4318907/ https://ncbi.nlm.nih.gov/pubmed/25343233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2572 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|